Amarin Corp. Plc (AMRN)
11.00
-0.26
(-2.31%)
USD |
NASDAQ |
Nov 20, 12:16
Amarin Cash from Investing (Quarterly) : 4.556M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.556M |
| June 30, 2026 | 6.124M |
| March 31, 2026 | -8.284M |
| December 31, 2025 | -3.540M |
| September 30, 2025 | -12.29M |
| June 30, 2025 | 12.57M |
| March 31, 2025 | 12.11M |
| December 31, 2024 | -22.75M |
| September 30, 2024 | -56.67M |
| June 30, 2024 | 4.722M |
| March 31, 2024 | 28.70M |
| December 31, 2023 | -71.30M |
| September 30, 2023 | 30.87M |
| June 30, 2023 | 34.59M |
| March 31, 2023 | -19.79M |
| December 31, 2022 | -25.84M |
| September 30, 2022 | 29.82M |
| June 30, 2022 | 72.71M |
| March 31, 2022 | 98.48M |
| December 31, 2021 | 24.82M |
| September 30, 2021 | -99.44M |
| June 30, 2021 | 50.34M |
| March 31, 2021 | 128.37M |
| December 31, 2020 | 22.42M |
| September 30, 2020 | -5.342M |
| Date | Value |
|---|---|
| June 30, 2020 | -102.97M |
| March 31, 2020 | -294.01M |
| December 31, 2019 | -0.3713M |
| September 30, 2019 | -1.314M |
| June 30, 2019 | -0.8034M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.0049M |
| September 30, 2018 | -0.053M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.0001M |
| June 30, 2017 | -0.0006M |
| March 31, 2017 | -0.0115M |
| December 31, 2016 | -0.0005M |
| September 30, 2016 | -0.0003M |
| June 30, 2016 | -0.0003M |
| March 31, 2016 | -0.0197M |
| December 31, 2015 | -0.018M |
| September 30, 2015 | -0.0099M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DBV Technologies SA | -5.302M |
| Akari Therapeutics Plc | 0.00 |
| Cellectis SA | 18.75M |
| Alkermes Plc | 19.99M |
| Alnylam Pharmaceuticals, Inc. | -311.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.218M |
| Cash from Financing (Quarterly) | -0.8254M |
| Free Cash Flow | 37.53M |
| Free Cash Flow Per Share (Quarterly) | 0.4309 |
| Free Cash Flow to Equity (Quarterly) | 9.120M |
| Free Cash Flow to Firm (Quarterly) | 9.218M |
| Free Cash Flow Yield | 16.18% |